Historically, the earliest general endoglin-based nuclear imaging study was reported by Fonsatti and coworkers in 2000, by radiolabeling the anti-endoglin monoclonal antibody MAEND3 with 125I and demonstrating specific imaging of breast cancer in a canine model [47]. Here, ENG is linked to breast cancer.